Previous 10 | Next 10 |
Bellerophon Therapeutics (NASDAQ: BLPH ) +67% on positive top-line data from a recently completed acute, intra-patient, dose escalation, hemodynamics study of INOpulse for the treatment of Pulmonary Hypertension associated with Pulmonary Fibrosis. More news on: Bellerophon Therape...
InMode ( INMD ) Q4 results : More news on: InMode Ltd., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
InMode (NASDAQ: INMD ): Q4 Non-GAAP EPS of $0.46 beats by $0.07 ; GAAP EPS of $0.46 beats by $0.08 . More news on: InMode Ltd., Earnings news and commentary, Healthcare stocks news, Read more ...
YOKNEAM, Israel, Feb. 18, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced financial results for the fourth quarter and full year ended December 31, 2019 . Fourth Quarter 2019 Highligh...
InMode (NASDAQ: INMD ) is scheduled to announce Q4 earnings results on Tuesday, February 18th, before market open. The consensus EPS Estimate is $0.39 and the consensus Revenue Estimate is $42.48M. Over the last 3 months, EPS estimates have seen 0 upward revisions and 0 dow...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Seven IPOs and one SPAC plan to raise $2.3 billion in the week ahead. While Casper Sleep's (CSPR) IPO down round creates more buzz about unprofitable unicorns, institutional investors are quietly eyeing drug development services provider PPD (PPD), set to be the year's second billion-dollar de...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
YOKNEAM, Israel , Jan. 29, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, will participate in the IMCAS World Congress, one of the largest European meetings of plastic and aesthetic surgeons, which will t...
Ocean Bio-Chem (NASDAQ: OBCI ) +80% as its subsidiary Star brite announces registered EPA product kills the Coronavirus . More news on: Ocean Bio-Chem, Inc., Happiness Biotech Group Limited, Delphi Technologies PLC, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...